Change in selectivity of estrogen receptor alpha ligand-binding domain by mutations at residues H524/L525
Open Access
- 14 February 2025
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1869 (4) , 130775
Abstract
No abstract availableKeywords
Funding Information
- National Council on Science and Technology (0316520-Fortalecimiento, 0316520, 594443)
- National Autonomous University of Mexico Directorate General of Academic Staff Affairs (IN226623, IN205722)
This publication has 29 references indexed in Scilit:
- Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancerActa Pharmaceutica Sinica B, 2023
- Comprehensive analysis of cellular estrogen signaling in representative estrogen receptor ligandsChemico-Biological Interactions, 2022
- Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-ChainACS Chemical Biology, 2018
- Engineering of Yarrowia lipolytica lipase Lip8p by circular permutation to alter substrate and temperature characteristicsJournal of Industrial Microbiology and Biotechnology, 2014
- A recombinant estrogen receptor fragment-based homogeneous fluorescent assay for rapid detection of estrogensBiosensors and Bioelectronics, 2014
- High-Throughput Screening of Enzyme Libraries: Thiolactonases Evolved by Fluorescence-Activated Sorting of Single Cells in Emulsion CompartmentsChemistry & Biology, 2005
- A novel pesticide‐induced conformational state of the oestrogen receptor ligand‐binding domain, detected by conformation‐specific peptide bindingFEBS Letters, 2004
- Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarizationAnalytical Biochemistry, 2004
- Molecular mechanisms of estrogen action: selective ligands and receptor pharmacologyThe Journal of Steroid Biochemistry and Molecular Biology, 2000
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973